Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-04-08
2008-04-08
Balasubram, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S194000, C544S206000, C544S207000
Reexamination Certificate
active
11546766
ABSTRACT:
In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]triazine compounds as inhibitors of kinases such as, for example, cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the kinases using such compounds or pharmaceutical compositions.
REFERENCES:
patent: 3846423 (1974-11-01), Kobe et al.
patent: 2230366 (1974-12-01), None
patent: WO 99/67247 (1999-12-01), None
patent: WO 02/50079 (2002-06-01), None
patent: WO 02/096348 (2002-12-01), None
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010, 1996.
Malumbres et al., Trends in Biochemical Sciences, 30(11), 630-641, 2005.
Lolli et al., Cell Cycle 4 :4, 572-577, 2005.
Sherr et al., Genes & Development 18, 2699-2711, 2004.
Fischer Cell Cycle 3:6, 742-746, 2004.
Wolft Manfred E. “Burger's Medicinal Chemistry, 5ed, Part 1”, John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al, “Modern Pharmaceutices, 3ed.”, Marcel Dekker, New York. 1996, pp. 451 and 596.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Vippagunta et al., Advanced Drug Delivery Reviews 48: 3-26, 2001.
Database-Accession No. 1112029 (BRN) 1988, XP002337892 Abstract & Helv. Chim. Acta. vol. 58. 1975. pp. 761-769.
Database-Accession No. 6197252 (BRN) 1988, XP002337893 Abstract & HETEROCYCLES, vol. 22, No. 2, 1984, pp. 345-351.
King F. D.: “Bioisosteres, Conformational Restriction, and Pro-Drugs . . . ” Med. Chem: Principles and Practice, Cambridge, RSC, GB, 1994, pp. 206-209, XP002033086.
International Search Report for PCT/US2005/005614—5pgs.
Guzi Timothy J.
Paruch Kamil
Balasubram Venkataraman
Kalyanaraman Palaiyur S.
Schering Corporation
LandOfFree
Pyrazolotriazines as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolotriazines as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolotriazines as kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3931061